Sun Pharma: Kirti Ganorkar to succeed Dilip Shanghvi as new MD

Published On 2025-06-14 07:01 GMT   |   Update On 2025-06-14 07:01 GMT

Mumbai: Sun Pharmaceutical Industries Limited has announced the appointment of Kirti Ganorkar as the company's next Managing Director, effective September 1, 2025, succeeding the company's current Managing Director, Dilip Shanghvi. In the new role, Ganorkar will take over the responsibility for the company’s entire business and functions  reporting to him.

This appointment is subject to approval of the shareholders at the upcoming Annual General Meeting. 

As Executive Chairman, Shanghvi will continue to chair the Board. He will focus on strengthening Sun Pharma’s specialty portfolio and provide insights towards shaping company’s long-term strategy, as per Sun Pharma's release.

Kirti Ganorkar has been heading India Business at Sun Pharma since June 2019. Under his leadership, the company’s India Business has grown consistently, further increasing its market share.

Previously, he has held various leadership roles across business development, marketing, M&A, new product introduction, project management, IP and litigation at Sun Pharma. He played a key role in driving Sun Pharma’s foray into specialty by securing rights for innovative products such as Ilumya. Kirti led Sun Pharma’s entry into Japan and laid initial groundwork for the company’s entry into Europe. He supported the U.S. business with stewardship of several notable generic projects from concept to commercialisation.

A chemical engineer and MBA, Kirti joined Sun Pharma in 1996.

Kirti Ganorkar, Managing Director (Designate) of Sun Pharma stated, "It has been a profoundly rewarding journey to participate in the company’s transformation into a leading global pharmaceutical enterprise. Sun Pharma is at an exciting juncture with all its businesses well-positioned for growth. Building on the strong foundation laid by Mr. Shanghvi and ably supported by our global leadership team, I’m confident of continued success of the company.”

Dilip Shanghvi, Chairman & Managing Director of Sun Pharma said, “Kirti has consistently demonstrated effective leadership managing diverse roles at Sun. I have a firm belief in his ability to lead the company into its next phase of growth and extend my best wishes for his success. Kirti’s elevation showcases our strong in-house talent pool, ensuring continuity of Sun’s core value systems.”

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News